Abiraterone Acetate
- Product NDC
- 60687-455
- 11-digit product format
- 606870455
- Labeler code
- 60687
- Product ID
- 60687-455_ec55c768-2329-060a-e053-2995a90add11
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abiraterone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA208327
- Marketing category
- ANDA
- Marketing start
- 2019-10-30
- Marketing end
- 0000-00-00
- Substance
- ABIRATERONE ACETATE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60687-455-21 | 60687045521 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-455-21) > 1 TABLET in 1 BLISTER PACK (60687-455-11) | 30 blister pack | 2019-10-15 | 0000-00-00 | No | No | Current |